News

73% of Respondents Had Never Heard of ATTR-CM, a Serious Heart Condition Where Women Face Later Diagnosis, Lower Treatment Rates, And Worse Outcomes CHICAGO,…

Cardiac amyloidosis on nuclear imaging of the heart using 11C-PiB PET/CT. Image courtesy of RSNACardiac amyloidosis research is a growing area in cardiology thanks…

OverviewThe study is conducted in participants with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a heart disease that occurs in people with the disease ATTR…

Transthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as a significant yet frequently overlooked etiology of heart failure, particularly within the elderly…

At AstraZeneca, we turn ideas into life-changing medicines. Working here means being entrepreneurial, thinking big, and collaborating to make the impossible a…

Transthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly recognized yet frequently underdiagnosed cause of heart failure, particularly among older…

AbstractCardiac amyloidosis (CA) is an infiltrative myocardiopathy caused by extracellular deposits of misfolded proteins, with evolution to heart failure (HF) and…

SGLT2i therapy reduces all-cause mortality and hospitalizations in transthyretin amyloid cardiomyopathy (ATTR-CM), according to a study being presented at Heart…

Findings from several studies presented at ESC Heart Failure Congress 2026 in Barcelona, Spain, were simultaneously published in JACC and JACC: Heart Failure,…

Background & AimCardiac amyloidosis is an infiltrative cardiomyopathy associated with significant morbidity and mortality. Frailty, a biologic syndrome of…